An increase in willingness to vaccinate against COVID-19 in the US between October 2020 and February 2021: longitudinal evidence from the Understanding America Study

Background: Recent evidence suggests that willingness to vaccinate against COVID-19 has been declining throughout the pandemic and is low among ethnic minority groups. Methods: Observational study using a nationally representative longitudinal sample (N =7,840) from the Understanding America Study (UAS). Changes in the percentage of respondents willing to vaccinate, undecided, or intending to refuse a COVID-19 vaccine were examined over 20 survey waves from April 1 2020 to February 15 2021. Results: After a sharp decline in willingness to vaccinate against COVID-19 between April and October 2020 (from 74.0% to 52.7%), willingness to vaccinate increased by 8.1% (p <.001) to 60.8% between October 2020 and February 2021. A significant increase in willingness to vaccinate was observed across all demographic groups examined and Black (15.6% increase) and Hispanic participants (12.1% increase) showed particularly large changes. Conclusions: Willingness to vaccinate against COVID-19 increased in the US from October 2020 to February 2021.

Trends in vaccination intentions between April 2020 and February 2021 are shown in Figure   1 3 8 1. There was a large drop in the percentage of participants willing to accept the vaccine from 73.8% at the beginning of April to 52.8% October 2020 that was observed in the overall 1 4 0 sample and across the demographic subgroups examined (see Table 2). At this point 1 4 1 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021. ; willingness to vaccinate was lowest among Black participants (47.1%). From October 2020 1 4 2 willingness to vaccinate increased and 60.9% of adults were willing be vaccinated by  In February 2021 29% of participants indicated they were unwilling to accept the 1 4 6 COVID-19 vaccine and this figure was particularly high among young adults, Black 1 4 7 participants, those without chronic conditions and lower income and education groups (see 1 4 8 Table 2). Marginal effects computed from a multinomial logistic regression confirmed that the 1 5 2 percentage of participants willing to accept the vaccine declined significantly by 21.3% (95% decline was observed across demographic subgroups (see Table 3) and was explained by an 1 5 5 increase in the percentage of participants reporting they are undecided (4.7% increase, 95% from 52.7% to 60.8% between October 2020 and February 2021 (see Table 3). This was indicating they were undecided about accepting the COVID-19 vaccine and a 3.2% (95% the vaccine from October 2020 to February 2021 (Table 3). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 8, 2021. ; Our regression analyses showed statistically significant increases in intentions to 1 6 5 vaccinate between October 2020 and February 2021 for all demographic groups examined 1 6 6 ( increases in willingness to vaccinate, as shown in Table 3. vaccines. After a rapid decline in intentions to vaccinate early in the pandemic, 5-7 willingness 1 7 6 to vaccinate increased by over eight percentage points from 52.7% to 60.8% among U.S. participants. This increase is important because COVID-19 vaccine acceptance has been 1 8 6 particularly low among Black and Hispanic groups who are known to experience a 1 8 7 disproportionate burden of severe illness and death due to COVID-19. 5,12,18 As such, CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021. ; achieving a high levels of vaccine uptake among ethnic minority groups is crucial to reduce 1 8 9 racial inequalities in disease outcomes due to COVID-19. However, despite the gains seen in 1 9 0 recent months vaccine acceptance remained under 50% in Black participants in February 1 9 1 2021 and just above 60% in the overall sample. Furthermore, approximately one in three 1 9 2 Black participants explicitly reported they will not be vaccinated (vaccine refusal) and this 1 9 3 figure was similarly high among other population sub-groups (e.g. young adults, lower 1 9 4 income and education groups). For this reason, public health messaging needs to continue to 1 9 5 communicate the safety, efficacy and necessity of COVID-19 vaccines and to build trust in 1 9 6 vaccines, particularly among Black populations. 12,19 1 9 7 Understanding the drivers of changes in vaccination acceptance will now be critical in shedding light on beliefs and concerns that could be targeted to promote vaccination uptake 1 9 9 and reduce loss of life due to the virus. 18 Recent evidence suggests that there has been a 2 0 0 decline in concern about the speed at which COVID-19 vaccines have been developed 2 0 1 suggesting that the U.S. population has been at least partly assured that the science continuously throughout the pandemic. However, the UAS is limited in that the survey is 2 1 0 administered to community dwelling adults in English and Spanish only and is accessible 2 1 1 only to those willing to engage with online surveys. This study is also limited in its reliance 2 1 2 on measures of intentions to vaccinate and reported vaccination behavior. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021. ; https://doi.org/10. 1101/2021 In conclusion, this longitudinal nationally representative study found that willingness 2 1 4 to vaccinate against COVID-19 has increased in the US from October 2020 to February 2021 2 1 5 and this increase has been largest in Black and Hispanic populations. However, almost 30% 2 1 6 of the US population still intend not to be vaccinated and continued efforts to improve 2 1 7 vaccine uptake are needed. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021.
Author Contributions: Dr Daly had full access to the study data and takes responsibility for 2 3 4 the integrity of the data and accuracy of the data analysis.

3 5
Concept and design: All authors.

3 6
Acquisition, analysis, or interpretation of data: All authors.

3 7
Drafting of the manuscript: All authors.

3 8
Critical revision of the manuscript for important intellectual content: All authors. Statistical analysis: Daly.   Council and their support is gratefully acknowledged. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021. ; announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency- https://www.fda.gov/news-events/press-announcements/fda-issues-emergency-use-  https://www.ssa.gov/policy/docs/ssb/v78n2/v78n2p13.html.  . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.   a Diagnosed with any of the following: diabetes, cancer, heart disease, kidney disease, asthma, 3 4 2 chronic lung disease, an autoimmune disease. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021. ; . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted March 8, 2021. ; Table 3. Graph is based on an analysis of 120,903 observations on 7,840 participants and estimates adjust for differences in demographic characteristics between survey waves. 95% confidence intervals are presented.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint a Responses were permitted for an additional two weeks after the allotted two-week slot for each survey wave and a small portion of responses (maximum ≈ 10%) of responses were made during this period and are included in the sample for each wave. b Number of observations included in the current study for each survey wave. c Indicates the percentage of the total number of participants included in the current study (N = 7,840) who have completed a survey in this wave.
. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted March 8, 2021. ;